logo-loader

Buds & Duds: Canopy Growth slips as CEO warns of bubble for cannabis industry

Last updated: 18:33 23 Jan 2019 EST, First published: 13:05 23 Jan 2019 EST

A marijuana plant

Cannabis stocks in the US and Canada had a down day Wednesday, trading in the same direction as the S&P/TSX Composite Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 0.4% to 259.86.

Duds:

Canopy Growth Corp (NYSE:CGC) (TSE:WEED) dropped 0.5% to US$43.45 in New York trading after CEO  Bruce Linton told CNBC at the World Economic Forum in Davos, Switzerland, that the cannabis industry faces a "massive inflationary bubble" and that investors should be careful.

"Everybody wants to be in the cannabis space, and I think investors have to be selective because … there will be a new name every week," Linton said.

READ: Canada's Canopy Growth shares bloom as it receives license to develop industrial hemp in New York

Merger speculation sank Aphria Inc (NYSE:APHA) (TSE:APHA). Its stock fell 2.3% to US$6.92 in New York on Wednesday after advising shareholders to take no action until its board has made a recommendation regarding an unsolicited takeover offer from Green Growth Brands Inc. (OTCMKTS:GGBXF) (CSE:GGB).

The agreement could value the Canadian cannabis company at  C$2.35 billion (US$1.76 billion).

In December, Aphria rejected Green Growth’s takeover bid on the grounds that it significantly undervalued the company.

Aphria fell 2.1% to C$9.23 in Canadian trading. Green Growth declined 2.3% to US$4.37 on the OTC Markets and was down 2.8% to C$5.81 in Canada.

Hexo Corp (TSE:HEXO) slipped 2.1% to C$6.92 in Toronto after earlier this week announcing a proposed offering of common shares of C$50 million (US$37 million).

In September, Riposte Capital, which owned 2.5% of the cannabis company, urged it to explore more deals.

Buds:

The Green Organic Dutchman Holdings (TSE:TGOD) (OTCQX:TGODF) shares climbed, up 2.7% at C$3.05.

Last week, the company announced it had tapped Dr Rav Kumar as its chief scientific officer.

Organigram Holdings Inc (OTCMKTS:OGRMF) (CVE:OGI) shares were up 0.2% to US$4.69 in OTC Markets trading after the licensed cannabis producer announced OrganiCare, a program designed to improve access to medical cannabis for low-income patients.

Effective immediately, patients who earn an annual income less than C$35,000 per year qualify for a 30% price reduction on dried cannabis products and oils, the New Brunswick company said.

The stock advanced 1.6% to C$6.26 in Canadian trading.

Contact Dennis Fitzgerald at dennis@proactiveinvestors.
 

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

42 minutes ago